An interventional study of Flexible Family Visitation Model (FFVM) and Restrictive Family Visitation Model (RFVM) in Delirium, sponsored by Hospital Moinhos de Vento. Completed at 33 sites in Brazil. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-11-23.
Sponsored by Hospital Moinhos de Vento · Not applicable, Interventional, and Prevention
A cluster-randomized crossover trial involving adult ICU patients, family members, and ICU professionals will be conducted. Forty medical-surgical Brazilian ICUs with visiting hours \<4.5 h/day will be randomly assigned to either a restrictive family visitation model (RFVM) (visits according to local policies) or a flexible family visitation model (FFVM) (visitation during 12 consecutive hours per day) at a 1:1 ratio. After enrollment and follow-up of 25 patients, each ICU will be switched over to the other visitation model, until 25 more patients per site are enrolled and followed. The primary outcome will be the cumulative incidence of delirium among ICU patients, measured twice a day using the Confusion Assessment Method for the ICU. Secondary outcome measures will include daily hazard of delirium, ventilator-free days at day 7, any ICU-acquired infections, ICU length of stay, and all-cause hospital mortality among the patients; symptoms of anxiety and depression and satisfaction among the family members; and prevalence of symptoms of burnout among the ICU professionals. Tertiary outcomes will include need for antipsychotic agents and/or mechanical restraints, coma-free days at day 7, unplanned loss of invasive devices, and ICU-acquired pneumonia, urinary tract infection, or bloodstream infection among the patients; self-perception of involvement in patient care among the family members; and satisfaction among the ICU professionals.
1,057 studies on the registry are indexed under Delirium; 238 are open to participants now.
This study's enrollment of 1,650 is above the median of 120 across 599 interventional studies indexed under Delirium.
Browse Delirium studies →Hospital Moinhos de Vento is the lead sponsor of 34 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
In the FFVM, two or fewer family members will be allowed to visit the patient for up to 12 consecutive hours each day. In addition to family visitation, patients will be allowed to receive social visits in specific time intervals (according local ICU regulation). To have access to the FFVM, family members of ICU patients will have to attend a structured meeting at ICU in which they will receive orientations about the ICU environment, common ICU treatments, rehabilitation and basic infection control practices, multidisciplinary work at ICU and palliative treatment. Social visitors will not be required to attend the structured meeting.
Other: Flexible Family Visitation Model (FFVM)
In the RFVM, patients will be allowed to receive restricted visits according routine ICU practices, but respecting the maximum limit of 4.5 hours of visitation per day. Visitors will not be required to attend the structured meeting. The length of ICU visits will be similar to those of social visits in the FFVM.
Other: Restrictive Family Visitation Model (RFVM)
Visitation to ICU patients allowed during the period of 12 consecutive hours per day.
Visitation to ICU patients allowed during intermittent periods according local ICU regulation.
Incidence of Delirium among ICU patients
Incidence of delirium will be verified by trained intensive care professionals with the confusion assessment method for the ICU 2 times per day.
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
Daily hazard of delirium among ICU patients
The daily hazard of delirium will be analyzed using a joint survival model that accounts for the treatment effect on repeated daily indicator of delirium (Confusion Assessment Method for the ICU) within each patient and terminating event (death or discharge from the ICU).
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
Antipsychotic use among ICU patients
Need of antipsychotic use during ICU stay
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
Need of mechanical restraints among ICU patients
Need of mechanical restraints among ICU patients during ICU stay
Time frame: During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)
Coma-free days at day 7 among ICU patients
Days alive and free of coma (Richmond Agitation Sedation Scale -4 or -5) during ICU stay.
Time frame: During the first 7 days following patient enrollment.
Unplanned loss of invasive devices among ICU patients
Unplanned loss of venous catheter, tube feeding or urinary catheter
Time frame: During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)
Mechanical ventilation-free days at day 7 among ICU patients
Days alive and free of mechanical ventilation during ICU stay.
Time frame: During the first 7 days following patient enrollment.
Any ICU-acquired infection among ICU patients
Pneumonia or bloodstream infection or urinary tract infection acquired after 48 hours of ICU admission.
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
ICU-acquired pneumonia among ICU patients
Pneumonia acquired after 48 hours of ICU admission.
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
ICU-acquired bloodstream infection among ICU patients
Bloodstream infection acquired after 48 hours of ICU admission.
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
ICU-acquired urinary tract infection among ICU patients
Urinary tract infection acquired after 48 hours of ICU admission.
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
ICU length of stay among ICU patients
Length of ICU stay in days
Time frame: During ICU stay (from enrollment until ICU discharge, or death or a maximum of 30 days of follow-up)
All-cause hospital mortality among ICU patients
rates of all-cause mortality during hospital stay
Time frame: During hospital stay (from enrollment until hospital discharge, or death or a maximum of 30 days of follow-up)
Symptoms of anxiety among family members
symptoms of anxiety among family members measured by the Hospital Anxiety and Depression scale
Time frame: IOn the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.
Symptoms of depression among family members
symptoms of depression among family members measured by the Hospital Anxiety and Depression scale
Time frame: On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.
Satisfaction among among family members
Rates of patient's families satisfaction measured by the critical care family needs inventory
Time frame: On the day of patient discharge from ICU, or death or a maximum of 30 days of follow-up.
Prevalence of Burnout Syndrome among ICU professionals
Prevalence of Burnout Syndrome among ICU workers measured by the Maslach Burnout Inventory
Time frame: It will be measured in two moments: within 15 days prior to the first ICU intervention and between the 15th and 30th days of the period in which no patient will be enrolled.
Satisfaction with the current ICU visiting policy among ICU professionals
Satisfaction with the current ICU visiting policy among ICU professionals
Time frame: It will be measured between the 15th and 30th days of the period in which no patient will be enrolled.
Any adverse event related to ICU visitation
Any adverse event possible related to the ICU visitation model
Time frame: During ICU stay (from randomization until ICU discharge, or death, or a maximum of 30 days of follow-up)
Plan to share: Undecided — The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
This study is completed, as verified in Nov 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Moinhos de Vento